Torthaí cuardaigh - Annette Juul Vangsted

Beachtaigh na torthaí
  1. 1
    The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study

    The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study de réir Henrik Gregersen, Annette Juul Vangsted, Niels Abildgaard, Niels Frost Andersen, Robert Schou Pedersen, Ulf Christian Frølund, Carsten Helleberg, Bettina Broch, Per Trøllund Pedersen, Peter Gimsing, Tobias Wirenfeldt Klausen

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study

    Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study de réir Rasmus Sørrig, Tobias Wirenfeldt Klausen, Morten Salomo, Annette Juul Vangsted, Brian Østergaard, Henrik Gregersen, Ulf Christian Frølund, Niels Frost Andersen, Carsten Helleberg, Kristian Andersen, Robert S. Pedersen, Per Trøllund Pedersen, Niels Abildgaard, Peter Gimsing

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population de réir Rasmus Sørrig, Tobias Wirenfeldt Klausen, Morten Salomo, Annette Juul Vangsted, Ulf Christian Frølund, Kristian Andersen, Anja Klostergaard, Carsten Helleberg, Robert S. Pedersen, Per Trøllund Pedersen, Sissel Helm‐Petersen, Elena Manuela Teodorescu, Birgitte Preiss, Niels Abildgaard, Peter Gimsing

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    The Danish National Multiple Myeloma Registry

    The Danish National Multiple Myeloma Registry de réir Peter Gimsing, Morten Orebo Holmström, Tobias Wirenfelt Klausen, Niels Frost Andersen, Henrik Gregersen, Robert Schou Pedersen, Torben Plesner, Per Trøllund Pedersen, Mikael Frederiksen, Ulf Christian Frølund, Carsten Helleberg, Annette Juul Vangsted, Peter de Nully Brown, Niels Abildgaard

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)

    Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14) de réir Nizar J. Bahlis, Rachid Baz, Simon J. Harrison, Hang Quach, Shir‐Jing Ho, Annette Juul Vangsted, Torben Plesner, Philippe Moreau, Simon Gibbs, Sheryl Coppola, Xiaoqing Yang, Abdullah Al Masud, Jeremy A. Ross, Orlando F. Bueno, Jonathan L. Kaufman

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma de réir Torben Plesner, Simon J. Harrison, Hang Quach, Cindy Lee, Adam Bryant, Annette Juul Vangsted, Jane Estell, Michel Delforge, Fritz Offner, Patrick J. Twomey, Voleak Choeurng, Junyi Li, Robert L. Hendricks, Shannon M. Ruppert, Teiko Sumiyoshi, Karen K. Miller, Eunpi Cho, Fredrik Schjesvold

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

    Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) de réir Evangelos Terpos, Monika Engelhardt, Gordon Cook, Francesca Gay, María‐Victoria Mateos, Ioannis Ntanasis‐Stathopoulos, Niels W.C.J. van de Donk, Hervé Avet‐Loiseau, Roman Hájek, Annette Juul Vangsted, Heinz Ludwig, Sonja Zweegman, Philippe Moreau, Hermann Einsele, Mario Boccadoro, Jesús F. San Miguel, Meletios Α. Dimopoulos, Pieter Sonneveld

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled... de réir Peter Gimsing, Kristina Carlson, Ingemar Turesson, Peter Fayers, Anders Waage, Annette Juul Vangsted, Anne K. Mylin, Christian Gluud, Gunnar Juliusson, Henrik Gregersen, Henrik Hjorth‐Hansen, Ingerid Nesthus, Inger Marie S. Dahl, Jan Westin, Johan Lanng Nielsen, Lene Meldgaard Knudsen, Lucia Ahlberg, Martin Hjorth, Niels Abildgaard, Niels Frost Andersen, Olle Linder, Finn Wislöff

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) de réir Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W.C.J. van de Donk, Ioannis Ntanasis‐Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Philippe Moreau, Hermann Einsele, Jesús F. San Miguel, Mario Boccadoro, Meletios Α. Dimopoulos, Pieter Sonneveld, Heinz Ludwig

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium

    Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium de réir Juan Sáinz, Carmen B. Lupiañez, Daniele Campa, Gabriele Buda, Hernan Moreno, Marek Dudziński, Charles Dumontet, Ramón García‐Sánz, Krzysztof Jamroziak, Artur Jurczyszyn, Stefano Landi, Fabienne Lesueur, Herlander Marques, Joaquín Martínez‐López, Vı́ctor Moreno, Mario Petrini, Rui Manuel Reis, Zofia Szemraj‐Rogucka, Annette Juul Vangsted, Judit Várkonyi, Ulla Vogel, Marzena Wątek, Federico Canzian, Rafael Ríos

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis

    A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis de réir Rafael Ríos, Carmen B. Lupiañez, Daniele Campa, Thomas Hielscher, Niels Weinhold, Joaquín Martínez‐López, Andrés Jerez, Stefano Landi, Krzysztof Jamroziak, Charles Dumontet, Marzena Wątek, Fabienne Lesueur, Rui Manuel Reis, Herlander Marques, Artur Jurczyszyn, Ulla Vogel, Gabriele Buda, Ramón García‐Sánz, Enrico Orciuolo, Mario Petrini, Annette Juul Vangsted, Federica Gemignani, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Federico Canzian, Manuel Jurado, Juan Sáinz

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

    Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma de réir Alessandro Di Martino, Daniele Campa, Krzysztof Jamroziak, Rui Manuel Reis, Juan Sáinz, Gabriele Buda, Ramón García‐Sánz, Fabienne Lesueur, Herlander Marques, Vı́ctor Moreno, Manuel Jurado, Rafael Ríos, Zofia Szemraj‐Rogucka, Janusz Szemraj, Anne Tjønneland, Kim Overvad, Annette Juul Vangsted, Ulla Vogel, Gábor Mikala, Katalin Kádár, Gergely Szombath, Judit Várkonyi, Enrico Orciuolo, Charles Dumontet, Federica Gemignani, Anna Maria Rossi, Stefano Landi, Mario Petrini, Richard S. Houlston, Kari Hemminki, Federico Canzian

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium

    Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium de réir Rafael Ríos, Carmen B. Lupiañez, Daniele Campa, Alessandro Di Martino, Joaquín Martínez‐López, Manuel Martínez‐Bueno, Judit Várkonyi, Ramón García‐Sánz, Krzysztof Jamroziak, Charles Dumontet, A Cayuela, Marzena Wętek, Stephano Landi, Anna Maria Rossi, Fabienne Lesueur, Rui Manuel Reis, Vı́ctor Moreno, Herlander Marques, Artur Jurczyszyn, Vibeke Andersen, Ulla Vogel, Gabriele Buda, Enrico Orciuolo, Svend Erik Hove Jacobsen, Mario Petrini, Annette Juul Vangsted, Federica Gemignani, Federico Canzian, Manuel Jurado, Juan Sáinz

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study

    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study de réir Niels W.C.J. van de Donk, Monique C. Minnema, Bronno van der Holt, Fredrik Schjesvold, Ka Lung Wu, Annemiek Broijl, Wilfried Roeloffzen, Alain Gadisseur, Giuseppe Pietrantuono, Luděk Pour, Vincent H. J. van der Velden, Thomas Lund, Massimo Offidani, Mariella Grasso, Luisa Giaccone, Wida Razawy, Paola Tacchetti, Katia Mancuso, Trine Silkjær, Jo Caers, Sonja Zweegman, Roman Hájek, Reuben Benjamin, Annette Juul Vangsted, Mario Boccadoro, Francesca Gay, Pieter Sonneveld, Pellegrino Musto

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma

    Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma de réir Bhairavi Swaminathan, Guðmar Þorleifsson, Magnus Jöud, Mina Ali, Ellinor Johnsson, Ram Ajore, Patrick Sulem, Britt-Marie Halvarsson, Guðmundur I. Eyjólfsson, Vilhelmína Haraldsdóttir, Christina M. Hultman, Erik Ingelsson, Sigurður Y. Kristinsson, Anna K. Kähler, Stig Lenhoff, Gísli Másson, Ulf‐Henrik Mellqvist, Robert Månsson, Sven Nelander, Ísleifur Ólafsson, Ólöf Sigurðardóttir, Hlíf Steingrímsdóttir, Annette Juul Vangsted, Ulla Vogel, Anders Waage, Hareth Nahi, Daníel F. Guðbjartsson, Þórunn Rafnar, Ingemar Turesson, Urban Gullberg, Kāri Stefánsson, Markus Hansson, Unnur Þorsteinsdóttir, Björn Nilsson

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

    Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length de réir Daniele Campa, Alessandro Di Martino, Judit Várkonyi, Fabienne Lesueur, Krzysztof Jamroziak, Stefano Landi, Artur Jurczyszyn, Herlander Marques, Vibeke Andersen, Manuel Jurado, Hermann Brenner, Mario Petrini, Ulla Vogel, Ramón García‐Sánz, Gabriele Buda, Federica Gemignani, Rafael Ríos, Annette Juul Vangsted, Charles Dumontet, Joaquín Martínez‐López, María José Moreno, Anna Stępień, Marzena Wątek, Vı́ctor Moreno, Aida Karina Dieffenbach, Anna Maria Rossi, Katja Butterbach, Svend Erik Hove Jacobsen, Hartmut Goldschmidt, Juan Sáinz, Jens Hillengaß, Enrico Orciuolo, Marek Dudziński, Niels Weinhold, Rui Manuel Reis, Federico Canzian

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

    Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients de réir Elad Ziv, Eric Déan, Donglei Hu, Alessandro Di Martino, Daniel Serie, Karen Curtin, Daniele Campa, Blake T. Aftab, Paige M. Bracci, Gabriele Buda, Yi Zhao, Jennifer L. Caswell‐Jin, Robert B. Diasio, Charles Dumontet, Marek Dudziński, Laura Fejerman, Alexandra J. Greenberg, Scott Huntsman, Krzysztof Jamroziak, Artur Jurczyszyn, Shaji Kumar, Djordje Atanackovic, Martha Glenn, Lisa Cannon‐Albright, Brandt Jones, Adam Lee, Herlander Marques, Thomas G. Martin, Joaquín Martínez‐López, S. Vincent Rajkumar, Juan Sáinz, Annette Juul Vangsted, Marzena Wątek, Jeffrey L. Wolf, Susan L. Slager, Nicola J. Camp, Federico Canzian, Celine M. Vachon

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma de réir Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Genetically determined telomere length and multiple myeloma risk and outcome

    Genetically determined telomere length and multiple myeloma risk and outcome de réir Matteo Giaccherini, Angelica Macauda, Enrico Orciuolo, Marcin Rymko, Karolina Gruenpeter, Charles Dumontet, Małgorzata Raźny, Vı́ctor Moreno, Gabriele Buda, Katia Beider, Judit Várkonyi, Hervé Avet‐Loiseau, Joaquín Martínez‐López, Herlander Marques, Marzena Wątek, María Eugenia Sarasquete, Vibeke Andersen, Lionel Karlin, Anna Suska, Marcin Kruszewski, Niels Abildgaard, Marek Dudziński, Aleksandra Butrym, Arnold L. Nagler, Annette Juul Vangsted, Katalin Kádár, Waldemar Tomczak, Krzysztof Jamroziak, Svend Erik Hove Jacobsen, Lene Hyldahl Ebbesen, Michał Taszner, Grzegorz Mazur, Fabienne Lesueur, Matteo Pelosini, Ramón García‐Sánz, Artur Jurczyszyn, Delphine Demangel, Rui Manuel Reis, Elżbieta Iskierka‐Jażdżewska, Mirosław Markiewicz, Federica Gemignani, Edyta Subocz, Daria Zawirska, Agnieszka Druzd‐Sitek, Anna Stępień, M. Henar Alonso, Juan Sáinz, Federico Canzian, Daniele Campa

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Identification of miRSNPs associated with the risk of multiple myeloma

    Identification of miRSNPs associated with the risk of multiple myeloma de réir Angelica Macauda, Diego Calvetti, Giuseppe Maccari, Kari Hemminki, Asta Försti, Hartmut Goldschmidt, Niels Weinhold, Richard S. Houlston, Vibeke Andersen, Ulla Vogel, Gabriele Buda, Judit Várkonyi, Anna Sureda, Joaquín Martínez‐López, Marzena Wątek, Aleksandra Butrym, María Eugenia Sarasquete, Marek Dudziński, Artur Jurczyszyn, Agnieszka Druzd‐Sitek, Marcin Kruszewski, Edyta Subocz, Mario Petrini, Elżbieta Iskierka‐Jażdżewska, Małgorzata Raźny, Gergely Szombath, Herlander Marques, Daria Zawirska, Dominik Chraniuk, Janusz Hałka, Svend Erik Hove Jacobsen, Grzegorz Mazur, Ramón García‐Sánz, Charles Dumontet, Vı́ctor Moreno, Anna Stępień, Katia Beider, Matteo Pelosini, Rui Manuel Reis, Małgorzata Krawczyk‐Kuliś, Marcin Rymko, Hervé Avet‐Loiseau, Fabienne Lesueur, Norbert Grząśko, Olga Ostrovsky, Krzysztof Jamroziak, Annette Juul Vangsted, Andrés Jerez, Waldemar Tomczak, Jan Maciej Zaucha, Katalin Kádár, Juan Sáinz, Arnon Nagler, Stefano Landi, Federica Gemignani, Federico Canzian

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: